GLP-1 Peptides and Glaucoma Risk: What We Know and What to Watch
A nationwide Danish registry study also found that GLP-1 agonist use was linked to a lower glaucoma risk. Compared to diabetic patients on other...
Eye Care Insights
Deep research and expert guides on maintaining your visual health.
Nerve Growth Factor–Based Peptides and Optic Nerve Protection
In a rabbit glaucoma model (pressure raised by a gel in the eye), researchers injected NGF around the eye (retrobulbar) before damage. Those rabbits...
Heat shock protein-derived peptides and autoimmunity in glaucoma
Evidence suggests that T cells (a type of white blood cell) reacting against HSPs can harm the optic nerve. For example, patient studies have found...
Endothelin pathway peptides and optic nerve head ischemia in glaucoma
ET-1 is produced by many eye tissues (retina, ciliary body, trabecular meshwork, etc.). It normally helps regulate blood flow and aqueous humor...
MOTS-c and Glaucoma: A Mitochondrial Signal With Bigger Implications Than Eye Pressure?
In 2015, researchers discovered MOTS-c – a 16-amino-acid peptide encoded in mitochondrial DNA (mtDNA) (). It is produced from a short open reading...
Senolytics and the Glaucoma Niche: Clearing Old Cells for Longer-Life Signals
Indeed, multiple studies have found senescence markers in RGCs and optic nerve tissue in glaucoma models. Notably, removing those old RGCs has been...
Ketogenic Signals and Beta-Hydroxybutyrate: IOP, Neuroprotection, and Longevity Intersections
The retina, especially RGCs, is a highly active tissue that needs a lot of energy to work. This energy comes from tiny structures in cells called...
The Glaucoma Energy Crisis: How Pyruvate Rescues Failing Eyes (And Why Your Fitness Level Matters)
Even if you load up on pyruvate, an inactive body won’t convert it to extra ATP unless it’s needed. Instead, the surplus pyruvate enters normal...
Photobiomodulation (670 nm) for Aging Retina: Lifespan Signals from Flies to Mammals
Photobiomodulation at 670 nm targets mitochondria, the tiny structures inside cells that make most of our energy (ATP). In mitochondria, a key enzyme...
What’s New in Glaucoma Research in April 2026? What Patients Should Know
What the study found: A new research report suggests that tiny leaks in tiny blood vessels in the eye may contribute to glaucoma damage. In simple...
A New Clue in Glaucoma: Leaky Blood Vessels May Damage Vision
One new idea is that damage to small retinal blood vessels might contribute to glaucoma. Normally, the tiny blood vessels in the retina have tight...
April 2026 Glaucoma Trial Launches: A Global Landscape Review
The April 2026 trials can be grouped by their main intervention modality:
Therapeutic Mechanisms Debuting in April 2026 Glaucoma Trials
Earlier trial results. A recent Phase III study (NCX 470) and others confirmed that combined outflow enhancers can beat traditional drops. For...
Gene- and Cell-Based Therapies Entering Glaucoma Trials in April 2026
Some trials deliver genes encoding neuroprotective factors into the eye to help RGCs survive. For example, one approach uses a harmless viral vector...
Home Tonometers and Contact Lens Sensors in April 2026 Protocols
Home readings can also serve as early safety signals. Protocols typically pre-specify pressure thresholds or warning rules. For instance, the...
Washout and Rescue Protocols in April 2026 IOP-Lowering Studies
Beta-blockers (e.g. timolol): These are typically washed out by stopping the drop for 4 weeks. Research showed that a 2-week break is usually too...
Hyperbaric Oxygen Therapy and Glaucoma: Mechanistic Rationale and Biological Plausibility
Breathing high oxygen through HBOT could boost the cells’ energy supply: with more oxygen available, mitochondria could produce more ATP and support...
Oxidative Stress, Hormesis, and the Hyperoxia Paradox in Glaucoma
In theory, brief exposure to high oxygen (like short HBOT sessions) could activate protective pathways inside eye cells. One key pathway involves the...
Take Your Free Visual Field Test
Screen your peripheral vision from home — no downloads, no waiting rooms. Sign up for a free trial and test in under 5 minutes.